Europe (WHO region) vs Oman: Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Europe (WHO region)
89.0%
in 2025
Oman
99.0%
in 2025
Europe (WHO region) rank
2nd
Oman rank
1st
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Europe (WHO region)
- Oman
How they compare
Oman currently reports 99.0% against 89.0% in Europe (WHO region), a difference of 10.0%.
That makes Oman's figure about 1.1 times Europe (WHO region)'s.
Across all 5 years both countries report, Oman has been ahead every year.
Europe (WHO region) ranks 2nd and Oman ranks 1st of 11 groups.
Oman has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Europe (WHO region) or Oman?
- Oman, at 99.0% against 89.0% in Europe (WHO region) as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Europe (WHO region) and Oman?
- 10.0%, with Oman ahead.
- How many years of comparable data are there for Europe (WHO region) and Oman?
- 5 years are reported by both, from 2021 to 2025.
- How do Europe (WHO region) and Oman rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Europe (WHO region) ranks 2nd and Oman ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.